Prediction of the risk of death in patients with severe pneumonia in ICUby NLR, PLR, hs-CRP

doi:10.3877/cma.j.issn.1674-6902.2021.03.019

Abstract

Bingyan Luo, Weihong Liu, Xiaoliang Zhang. Prediction of the risk of death in patients with severe pneumonia in ICUby NLR, PLR, hs-CRP[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2021, 14(03): 338-340.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhfbjbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-6902.2021.03.019

https://zhfbjbzz.cma-cmc.com.cn/EN/Y2021/V14/I03/338

Figures/Tables 2

References 30

1	Mizgerd JP. Pathogenesis of severe pneumonia: advances and knowledge gaps[J]. Curr Opin Pulm Med, 2017, 23(3): 193-197.
2	Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis[J]. J Thromb Haemost, 2020, 18(7): 1738-1742.
3	Spiezia L, Boscolo A, Poletto F, et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure[J]. Thromb Haemost, 2020, 120(6): 998-1000.
4	Karasahin O, Tasar PT, Timur O, et al. The value of C-reactive protein in infection diagnosis and prognosis in elderly patients[J]. Aging Clin Exp Res, 2018, 30(6): 555-562.
5	Choi JJ, McCarthy MW. Novel applications for serum procalcitonin testing in clinical practice[J]. Expert Rev Mol Diagn, 2018, 18(1): 27-34.
6	李　萌，姚　莉，王　菁，等. NLR PLR在评估重症肺炎患者预后中的价值[J]. 安徽医学，2020, 41(4): 106-109.
7	Cai Z, He W, Zhuang FJ, et al. The role of high high-sensitivity C-reactive protein levels at admission on poor prognosis after acute ischemic stroke[J]. Int J Neurosci, 2019, 129(5): 423-429.
8	中国医师协会急诊医师分会. 中国急诊重症肺炎临床实践专家共识[J]. 中国急救医学，2016, 36(2): 97-107.
9	Gilani MT, Razavi M, Azad AM. A comparison of simplified acute physiology score Ⅱ，acute physiology and chronic health evaluation Ⅱ and acute physiology and chronic health evaluation Ⅲ scoring system in predicting mortality and length of stay at surgical intensive care unit[J]. Niger Med J, 2014, 55(2): 144-147.
10	Heppner HJ, Sehlhoff B, Niklaus D, et al. Pneumonia severity index (PSI), CURB-65, and mortality in hospitalized elderly patients with aspiration pneumonia[J]. Z Gerontol Geriatr, 2011, 44(4): 229-234.
11	Klopfenstein T, Zayet S, Lohse A, et al. Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients[J]. Med Mal Infect, 2020, 50(5): 397-400.
12	Chahin A, Opal SM. Severe pneumonia caused by legionella pneumophila：differential diagnosis and therapeutic considerations[J]. Infect Dis Clin North Am, 2017, 31(1): 111-121.
13	Spiezia L, Boscolo A, Poletto F, et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure[J]. Thromb Haemost, 2020, 120(6): 998-1000.
14	梁　欢，高　烨，苗常青，等. 中性粒细胞/淋巴细胞比值对重症肺炎患者28 d死亡风险的预测价值[J]. 中华危重病急救医学，2019, 31(7): 827-831.
15	Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis[J]. J Med Virol, 2020, 92(10): 1733-1734.
16	Zhou Y, Guo S, He Y, et al. COVID-19 is distinct from sars-cov-2-negative community-acquired pneumonia[J]. Front Cell Infect Microbiol, 2020, 10: 322.
17	Yang AP, Liu JP, Tao WQ, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients[J]. Int Immunopharmacol, 2020, 84(12): 106-112.
18	Qu R, Ling Y, Zhang YH, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19[J]. J Med Virol, 2020, 92(9): 1533-1541.
19	Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19[J]. J Infect, 2020, 81(1): e6-e12.
20	Seyit M, Avci E, Nar R, et al. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19[J]. Am J Emerg Med, 2021, 40(15): 110-114.
21	Ge YL, Liu CH, Xu J, et al. Serum high-sensitivity c reactive protein improves sensitivity of curb-65 in predicting icu admission and mortality in community-acquired pneumonia patients[J]. Clin Lab, 2018, 64(10): 1749-1754.
22	Nam KW, Kim TJ, Lee JS, et al. High neutrophil-to-lymphocyte ratio predicts stroke-associated pneumonia[J]. Stroke, 2018, 49(8): 1886-1892.
23	Lee JH, Song S, Yoon SY, et al. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as diagnostic markers for pneumonia severity[J]. Br J Biomed Sci, 2016, 73(3): 140-142.
24	Wang C, Deng R, Gou L, et al. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters[J]. Ann Transl Med, 2020, 8(9): 593.
25	姜迎厚，王　瑛，韩云宏，等. NLR评估老年重症肺炎严重程度及预后的价值[J]. 临床肺科杂志，2018, 23(12): 2170-2174.
26	Kartal O, Kartal AT. Value of neutrophil to lymphocyte and platelet to lymphocyte ratios in pneumonia[J]. Bratisl Lek Listy, 2017, 118(9): 513-516.
27	Neeser OL, Vukajlovic T, Felder L, et al. A high C-reactive protein/ procalcitonin ratio predicts Mycoplasma pneumoniae infection[J]. Clin Chem Lab Med, 2019, 57(10): 1638-1646.
28	Paul SP, De Aguiar A, Barnden J, et al. Outcomes of very high C-reactive protein levels in paediatric practice[J]. Br J Nurs, 2018, 27(1): 51.
29	Ali A, Abbasi AS, Amjad T, et al. Erythrocyte sedimentation rate and c-reactive protein as marker of acute versus chronic medical conditions[J]. J Ayub Med Coll Abbottabad, 2019, 31(1): 39-45.
30	周　燕. 重症肺部感染患者机械通气前后hs-CRP，PCT的变化情况及其与患者预后的关系分析[J]. 标记免疫分析与临床，2018, 25(2): 215-219+223.

临床资料	死亡组(n＝35)	存活组(n＝81)	χ^/t值	P值
性别　男/女	19/16	43/38	0.014	0.905
年龄(岁)	59.58±8.12	57.84±8.06	1.065	0.289
入住ICU时间(d)	15.27±2.15	12.08±1.67	4.476	<0.001
体温(℃)	38.48±1.29	38.73±1.08	1.078	0.283
吸烟史	15(42.86)	23(28.40)	2.321	0.128
饮酒史	17(48.57)	28(34.57)	2.018	0.155
意识障碍	15(42.86)	21(25.93)	3.273	0.070
吞咽障碍	9(25.71)	12(14.81)	1.958	0.162
机械通气	22(62.86)	30(37.04)	6.588	0.010
APACHEⅡ评分(分)	35.26±6.85	23.28±6.15	9.302	<0.001
PSI评分(分)	98.76±10.27	72.15±8.63	14.377	<0.001
C反应蛋白(mg/ml)	76.95±9.82	58.12±8.97	10.084	<0.001
WBC(×10⁹/L)	13.32±3.25	11.46±2.84	3.098	0.002
血清白蛋白(g/L)	25.15±3.54	26.27±3.96	1.442	0.152
血清NLR	9.81±1.56	5.43±1.06	17.596	<0.001
血清PLR	201.38±16.24	173.42±12.33	10.153	<0.001
血清hs-CRP(mg/L)	27.85±5.36	18.25±5.12	9.139	<0.001

临床资料	死亡组(n＝35)	存活组(n＝81)	χ^/t值	P值
性别　男/女	19/16	43/38	0.014	0.905
年龄(岁)	59.58±8.12	57.84±8.06	1.065	0.289
入住ICU时间(d)	15.27±2.15	12.08±1.67	4.476	<0.001
体温(℃)	38.48±1.29	38.73±1.08	1.078	0.283
吸烟史	15(42.86)	23(28.40)	2.321	0.128
饮酒史	17(48.57)	28(34.57)	2.018	0.155
意识障碍	15(42.86)	21(25.93)	3.273	0.070
吞咽障碍	9(25.71)	12(14.81)	1.958	0.162
机械通气	22(62.86)	30(37.04)	6.588	0.010
APACHEⅡ评分(分)	35.26±6.85	23.28±6.15	9.302	<0.001
PSI评分(分)	98.76±10.27	72.15±8.63	14.377	<0.001
C反应蛋白(mg/ml)	76.95±9.82	58.12±8.97	10.084	<0.001
WBC(×10⁹/L)	13.32±3.25	11.46±2.84	3.098	0.002
血清白蛋白(g/L)	25.15±3.54	26.27±3.96	1.442	0.152
血清NLR	9.81±1.56	5.43±1.06	17.596	<0.001
血清PLR	201.38±16.24	173.42±12.33	10.153	<0.001
血清hs-CRP(mg/L)	27.85±5.36	18.25±5.12	9.139	<0.001

因　素	β	SE	Wald	P值	OR	95%CI
PSI评分	1.342	0.425	9.971	0.035	3.827	1.052～4.716
血清NLR	1.471	0.306	23.109	<0.001	4.354	3.158～9.543
血清PLR	1.203	0.342	12.373	0.012	3.327	2.185～7.216
血清hs-CRP	1.017	0.358	8.070	0.023	2.765	2.057～5.417

因　素	β	SE	Wald	P值	OR	95%CI
PSI评分	1.342	0.425	9.971	0.035	3.827	1.052～4.716
血清NLR	1.471	0.306	23.109	<0.001	4.354	3.158～9.543
血清PLR	1.203	0.342	12.373	0.012	3.327	2.185～7.216
血清hs-CRP	1.017	0.358	8.070	0.023	2.765	2.057～5.417

Please choose a citation manager

Content to export

Prediction of the risk of death in patients with severe pneumonia in ICUby NLR, PLR, hs-CRP

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

Figures/Tables 2

References 30

Related Articles 0

Recommended Articles

Metrics

Comments

模态框（Modal）标题

Please choose a citation manager

Content to export

Prediction of the risk of death in patients with severe pneumonia in ICUby NLR, PLR, hs-CRP

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

Figures/Tables 2

References 30

Related Articles 0

Recommended Articles

Metrics

Comments